Innate Pharma (IPH) — Financial Flexibility Index
Innate Pharma (IPH) has a Financial Flexibility Index of -0.25x as of December 2025. Free cash flow of €-21.51 Million (operating CF €-21.59 Million minus capex €82.00K) represents 0% of total liabilities (€84.42 Million). Check asset allocation strategy of Innate Pharma to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Innate Pharma Financial Flexibility Index (2005–2025)
Historical Financial Flexibility Index trend for Innate Pharma across 21 annual periods. See Innate Pharma (IPH) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Innate Pharma (2005–2025)
Year-by-year free cash flow to debt coverage for Innate Pharma. For the full company profile including market capitalisation, see IPH market cap.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.62x | €-52.62 Million | €-52.76 Million | €84.42 Million | ▼ -879.4% |
| 2024 | -0.06x | €-6.50 Million | €-6.90 Million | €102.22 Million | ▲ +72.1% |
| 2023 | -0.23x | €-30.21 Million | €-32.56 Million | €132.29 Million | ▼ -94.6% |
| 2022 | -0.12x | €-18.03 Million | €-19.15 Million | €153.71 Million | ▲ +67.1% |
| 2021 | -0.36x | €-57.13 Million | €-58.46 Million | €160.06 Million | ▼ -33.4% |
| 2020 | -0.27x | €-40.52 Million | €-51.81 Million | €151.45 Million | ▼ -149.1% |
| 2019 | 0.55x | €100.33 Million | €34.92 Million | €183.94 Million | ▲ +598.0% |
| 2018 | -0.11x | €-31.10 Million | €-32.53 Million | €283.98 Million | ▲ +55.9% |
| 2017 | -0.25x | €-42.03 Million | €-48.06 Million | €169.07 Million | ▼ -76.9% |
| 2016 | -0.14x | €-27.46 Million | €-36.85 Million | €195.41 Million | ▼ -115.3% |
| 2015 | 0.92x | €215.31 Million | €207.91 Million | €233.89 Million | ▲ +193.6% |
| 2014 | -0.98x | €-15.79 Million | €-18.13 Million | €16.06 Million | ▼ -45.5% |
| 2013 | -0.68x | €-10.53 Million | €-10.97 Million | €15.60 Million | ▼ -82.0% |
| 2012 | -0.37x | €-9.25 Million | €-10.47 Million | €24.93 Million | ▼ -193.4% |
| 2011 | 0.40x | €13.31 Million | €12.99 Million | €33.48 Million | ▲ +144.2% |
| 2010 | -0.90x | €-13.04 Million | €-13.45 Million | €14.49 Million | ▼ -183.6% |
| 2009 | -0.32x | €-5.42 Million | €-5.94 Million | €17.10 Million | ▲ +51.8% |
| 2008 | -0.66x | €-12.84 Million | €-14.74 Million | €19.52 Million | ▼ -11.6% |
| 2007 | -0.59x | €-7.99 Million | €-9.28 Million | €13.55 Million | ▼ -783.1% |
| 2006 | 0.09x | €1.11 Million | €360.00K | €12.89 Million | ▲ +105.7% |
| 2005 | -1.52x | €-7.14 Million | €-7.25 Million | €4.70 Million | — |